SOX2 as a novel contributor of oxidative metabolism in melanoma cells

BACKGROUND: Deregulated metabolism is a hallmark of cancer and recent evidence underlines that targeting tumor energetics may improve therapy response and patient outcome. Despite the general attitude of cancer cells to exploit the glycolytic pathway even in the presence of oxygen (aerobic glycolysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreucci, Elena, Pietrobono, Silvia, Peppicelli, Silvia, Ruzzolini, Jessica, Bianchini, Francesca, Biagioni, Alessio, Stecca, Barbara, Calorini, Lido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249961/
https://www.ncbi.nlm.nih.gov/pubmed/30466459
http://dx.doi.org/10.1186/s12964-018-0297-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249961/
https://www.ncbi.nlm.nih.gov/pubmed/30466459
http://dx.doi.org/10.1186/s12964-018-0297-z

Ejemplares similares